Animab: Funding, Investors & Team (Sep 2026)
Animab is a biotech company that focuses on developing unique technology to enhance the health of livestock. Through a combination of advanced research, animal science, and biotech, Animab produces products that enhance animal health, decrease expenses, and promote sustainability. Specifically, Animab offers a safe and sustainable solution for safeguarding the intestinal health of piglets after weaning. The antibodies in Animab mimic secretory IgA, a natural antibody passed on through colostrum and milk to safeguard nursing animals.
Animab has raised $11.8M across 1 funding round on record, the most recent a Series B of $11.8M announced in Jul 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Animab Company Profile and Key Stats
Latest funding round on record: Jul 2025.
Animab Funding Rounds
Animab Founders and Leadership Team
Contact details for the Animab team: 1 of 1 has an email address on file.
Start 14-day free trial →Animab Funding Compared to Other Biotechnology Startups
Animab's latest round of $11.8M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Animab in Biotechnology and Gent
Companies Similar to Animab
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
Nyxoah is a health-technology company focused on the development and commercialization of innovative…
Coultreon Biopharma is developing best-in-class therapeutics that target clinically validated pathways in…
neuroClues provides easy-to-use eye-tracking environment to help practitioners instantaneously quantify their…
Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells,…
Confo Therapeutics is a company focused on drug discovery, specifically targeting GPCRs to address medical…
Augustine Therapeutics company is conducting two drug discovery programs in order to discover new generations…
4Tissue is a company focused on research and clinical trials that creates remedies to address the challenges…
Tavira Therapeutics creates an innovative platform to improve the delivery of genes using AAV. By adding…
AgomAb is creating sub-atomic treatments for the recovery of harmed tissues. Their exceptional agonistic…
BioSourcing is developing a New Generation of Biotherapeutics, in particular Monoclonal Antibodies for Global…
Animab Funding FAQs
What does Animab do?
Animab is a biotech company that focuses on developing unique technology to enhance the health of livestock. Through a combination of advanced research, animal science, and biotech, Animab produces products that enhance animal health, decrease expenses, and promote sustainability. Specifically, Animab offers a safe and sustainable solution for safeguarding the intestinal health of piglets after weaning. The antibodies in Animab mimic secretory IgA, a natural antibody passed on through colostrum and milk to safeguard nursing animals.
How much funding has Animab raised?
Animab has raised $11.8M across 1 round on record. The most recent is a Series B of $11.8M announced in Jul 2025.
When did Animab last raise funding?
Animab's most recent funding round on record is a Series B of $11.8M, announced in Jul 2025.
Who founded Animab?
FundedIQ lists Vikram Virdi (Founder) at Animab.
Where is Animab headquartered?
Animab is based in Gent, Oost-Vlaanderen, Belgium.
How many employees does Animab have?
Animab is in the 11-50 employee band.
How does Animab's funding compare to other Biotechnology startups?
Animab's latest round of $11.8M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Animab Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Animab is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.